Neurol. praxi. 2015;16(6):366-369

De novo development of super-refractory status epilepticus

MUDr. Iva Marečková, MUDr. Zdeněk Vojtěch, MUDr. Tomáš Procházka, MUDr. Denisa Vondráčková
Neurologické oddělení Nemocnice Na Homolce, Praha

Cryptogenic new onset refractory status epilepticus (NORSE) syndrome has been described in both adults and children, and is often associated with poor outcome. A variety of terms have been used in the literature to refer to this syndrom. The condition may be triggered by as yet unidentified infections or an immunological mechanism. Early use of immunotherapy appears to be associated with better neurological outcomes.

Keywords: status epilepticus, immunotherapy, encephalitis

Published: December 16, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marečková I, Vojtěch Z, Procházka T, Vondráčková D. De novo development of super-refractory status epilepticus. Neurol. praxi. 2015;16(6):366-369.
Download citation

References

  1. Baxter P, Clarke A, Cross H, Harding B, Hicks E, Livingston J, Surtees R.Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure 2003; 12: 379-387. Go to original source... Go to PubMed...
  2. Costello DJ, Kilbride RD, Cole AJ. Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not? J Neurol Sci 2009; 277: 26-31. Go to original source... Go to PubMed...
  3. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46: 1029-1035. Go to original source... Go to PubMed...
  4. Gall CR, Jumma O, Mohanraj R. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.Seizure 2013; 22: 217-220. Go to original source... Go to PubMed...
  5. Krýsl D, Marusič P. Autoimunní limbické encefalitidy. Neurol. praxi 2012; 13: 160-164.
  6. Rathakrishnan R, Wilder-Smith EP. New onset refractory status epilepticus (NORSE). J Neurol Sci 2009; 284: 220; author reply 220-221. Go to original source... Go to PubMed...
  7. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia 2011; 52(Suppl 8): 53-56. Go to original source... Go to PubMed...
  8. Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, Ong BK. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity.Ann Acad Med Singapore 2005; 34: 417-420.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.